1,029
Participants
Start Date
November 24, 2015
Primary Completion Date
June 1, 2017
Study Completion Date
June 1, 2017
insulin degludec/insulin aspart
Ryzodeg™ will be prescribed by the physician under normal clinical practice conditions and will be obtained/purchased from the chemist based on physician prescription. No treatment given.
Novo Nordisk Investigational Site, Noida
Novo Nordisk Investigational Site, Lucknow
Novo Nordisk Investigational Site, Jaipur
Novo Nordisk Investigational Site, Ahmedabad
Novo Nordisk Investigational Site, Ahmedabad
Novo Nordisk Investigational Site, Gandhinagar
Novo Nordisk Investigational Site, Surat
Novo Nordisk Investigational Site, Mumbai
Novo Nordisk Investigational Site, Pune
Novo Nordisk Investigational Site, Indore
Novo Nordisk Investigational Site, Bilāspur
Novo Nordisk Investigational Site, Vijayawada
Novo Nordisk Investigational Site, Guntur
Novo Nordisk Investigational Site, Visakhapatnam
Novo Nordisk Investigational Site, Bangalore
Novo Nordisk Investigational Site, Mangalore
Novo Nordisk Investigational Site, Chennai
Novo Nordisk Investigational Site, Chennai
Novo Nordisk Investigational Site, Coimbatore
Novo Nordisk Investigational Site, Kochi
Novo Nordisk Investigational Site, Kolkata
Novo Nordisk Investigational Site, Ahmedabad
Novo Nordisk Investigational Site, Ghuma
Novo Nordisk Investigational Site, Bangalore
Novo Nordisk Investigational Site, Angamaly
Novo Nordisk Investigational Site, Thrissur
Novo Nordisk Investigational Site, Trivandrum
Novo Nordisk Investigational Site, Indore
Novo Nordisk Investigational Site, Amritsar
Novo Nordisk Investigational Site, Chandigarh
Novo Nordisk Investigational Site, Jaipur
Novo Nordisk Investigational Site, Chennai
Novo Nordisk Investigational Site, Lucknow
Novo Nordisk Investigational Site, Madurai
Novo Nordisk Investigational Site, Thriruvananthapuram
Lead Sponsor
Novo Nordisk A/S
INDUSTRY